Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-6,127
Closed -$263K – 89
2018
Q1
$263K Buy
6,127
+326
+6% +$13.7K 0.16% 80
2017
Q4
$261K Sell
5,801
-9,093
-61% -$542K 0.15% 83
2017
Q3
$1M Buy
14,894
+5,165
+53% +$324K 0.56% 72
2017
Q2
$584K Sell
9,729
-1,017
-9% -$65.7K 0.32% 79
2017
Q1
$711K Sell
10,746
-4,557
-30% -$319K 0.41% 77
2016
Q4
$1.08M Sell
15,303
-3,242
-17% -$202K 0.63% 76
2016
Q3
$1.1M Sell
18,545
-14,740
-44% -$723K 0.68% 74
2016
Q2
$1.39M Buy
33,285
+30
+0.1% +$1.08K 0.89% 66
2016
Q1
$1.17M Buy
33,255
+20,930
+170% +$657K 0.7% 71
2015
Q4
$399K Buy
+12,325
New +$444K 0.26% 88

Other funds holding AGX

Delphi Management's AGX Position: Q2 2018 in Review

Delphi Management sold out of Argan (AGX) in Q2 2018, closing a stake of 6,127 shares — an estimated $263K sold.

Delphi Management first reported a position in AGX in Q4 2015 and held it in 10 quarters. The position peaked at $1.39M in Q2 2016. 149 funds tracked by Wall St. Rank hold AGX as of Q2 2018.

  • Delphi Management reported no remaining Argan position as of Q2 2018 after selling out during the quarter.
  • Delphi Management sold 6,127 Argan shares in Q2 2018, an estimated $263K.
  • Delphi Management first reported a position in Argan in Q4 2015 and held it in 10 quarters.
  • Delphi Management's Argan position peaked at $1.39M in Q2 2016.
  • 149 funds tracked by Wall St. Rank held Argan as of Q2 2018.

Based on Delphi Management's 13F filing for Q2 2018, filed 20 Aug 2018.